Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial

Aaron I. Vinik, Vera Bril, Péter Kempler, William J. Litchy, Solomon Tesfaye, Karen Price, Edward J. Bastyr

Clinical Therapeutics · 2005 · 172 citations · 63 references

Concepts

References

63